The Recall Desk
ModerateFDA (Devices)·Z-1619-2020·Announced 2020-04-08

Binding Site C-Reactive Protein Kit Recalled for Reagent Performance Issues

The Binding Site Group is recalling C-Reactive Protein Kits because a reagent is not performing to specification, potentially affecting low-concentration samples.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations, injuries, or illnesses, fitting the criteria for a moderate severity precautionary recall.

Plain-English summary

The Binding Site Group, Ltd. is recalling C-Reactive Protein Kits (REF NK044.S.A) intended for use on the SPAplus analyzer. The recall is limited to Lot 455672, which was distributed in Florida.

The recall was initiated because a reagent in the kits is not performing to specification. This defect may affect samples with known concentrations less than or equal to 10 mg/L. The product is prescription-only.

Healthcare facilities and laboratories that have received this specific lot should stop using the kits and contact the manufacturer for instructions on return or replacement.

The recalled product

Product
C-Reactive Protein Kit for use on the SPAplus, REF NK044.S.A, Rx only, UDI (01)05051700018456,
Affected units
1

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 455672

Distribution

Distributed in 1 state: